Thomas J. Humphries

Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: The U.S. multicenter study

Stephen J. Sontag, Basil I. Hirschowitz, S. Holt et al. · Gastroenterology · 1992 · 175 citations

U.s. Multicenter Study, Esophagus, Symptomatic Erosive Esophagitis +6

Rabeprazole in Treatment of Acid Peptic Diseases (Results of Three Placebo-Controlled Dose-Response Clinical Trials in Duodenal Ulcer, Gastric Ulcer, and Gastroesophageal Reflux Disease (GERD))

M. L. Cloud, Nathan Enas, Thomas J. Humphries et al. · Digestive Diseases and Sciences · 1998 · 116 citations

Anti-inflammatory Agents, Gastrointestinal Pharmacology, Acid Peptic Diseases +7

Pressure profile of esophageal peristalsis in normal humans as measured by direct intraesophageal transducers

Thomas J. Humphries, Donald O. Castell · Digestive Diseases and Sciences · 1977 · 81 citations

Esophagus, Direct Intraesophageal Transducers, Gastroenterology +6

Steroid-sparing properties of sargramostim in patients with corticosteroid-dependent Crohn’s disease: a randomised, double-blind, placebo-controlled, phase 2 study

John F. Valentine, Richard N. Fedorak, Brian G. Feagan et al. · Gut · 2009 · 61 citations

Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: A double-blind, randomized clinical trial

Alain Farley, Lawrence D. Wruble, Thomas J. Humphries · The American Journal of Gastroenterology · 2000 · 61 citations